4 minute read
FAQ: Insights into Compliant Large-Scale Cell Line Screening Solutions
April 18, 2024
Zhengzheng currently serves as Director, Head of Oncology In Vitro at Crown Bioscience, following the completion of his PhD and Postdoc at the University of Liverpool and Liverpool Royal Hospital, respectively. He has always aspired to work in an organization that helps deliver innovative, effective medicines that make a real difference in fighting cancer. With over ten years’ experience in the cancer research field, with the aim of finding and improving diagnostic, prognostic and metastasis markers for cancers, it is a job the Zhengzheng gives their entire effort and energy to each day.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-05-23
2022-12-16